Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 15694360)

Published in Biochem Biophys Res Commun on March 11, 2005

Authors

Chao Qi1, Yiwei Tony Zhu, Jeffrey Chang, Anjana V Yeldandi, M Sambasiva Rao, Yi-Jun Zhu

Author Affiliations

1: Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Articles citing this

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One (2009) 4.62

Comprehensive copy number profiles of breast cancer cell model genomes. Breast Cancer Res (2006) 2.02

Nuclear receptor coregulators in cancer biology. Cancer Res (2009) 1.51

Regulation of plant innate immunity by three proteins in a complex conserved across the plant and animal kingdoms. Genes Dev (2007) 1.38

Genomic interaction profiles in breast cancer reveal altered chromatin architecture. PLoS One (2013) 0.88

ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells. Br J Cancer (2014) 0.88

BCAS2 is essential for Drosophila viability and functions in pre-mRNA splicing. RNA (2012) 0.82

Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses. Proteome Sci (2011) 0.80

BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability. Br J Cancer (2014) 0.79

BCAS2 Regulates Delta-Notch Signaling Activity through Delta Pre-mRNA Splicing in Drosophila Wing Development. PLoS One (2015) 0.77

Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator. Mol Endocrinol (2010) 0.76

Conditional Knockout of Breast Carcinoma Amplified Sequence 2 (BCAS2) in Mouse Forebrain Causes Dendritic Malformation via β-catenin. Sci Rep (2016) 0.75

Articles by these authors

Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet (2012) 4.82

High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc (2008) 3.92

Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol (2006) 3.59

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem (2002) 3.24

Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc (2006) 2.89

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80

Signet-ring cell change versus signet-ring cell carcinoma: a comparative analysis. Am J Surg Pathol (2003) 2.51

NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13

Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology. Arch Pathol Lab Med (2013) 2.11

Identification of the MLL2 complex as a coactivator for estrogen receptor alpha. J Biol Chem (2006) 1.92

Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol (2006) 1.87

Gene transfer of the Na+,K+-ATPase beta1 subunit using electroporation increases lung liquid clearance. Am J Respir Crit Care Med (2004) 1.79

Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer (2009) 1.49

Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver. J Biol Chem (2004) 1.40

Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc Natl Acad Sci U S A (2002) 1.36

Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J Biol Chem (2002) 1.36

Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J Biol Chem (2001) 1.32

Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis. J Biol Chem (2003) 1.27

Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gamma. J Biol Chem (2007) 1.23

Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem (2002) 1.15

Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase. J Biol Chem (2002) 1.12

Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J (2011) 1.10

Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res (2003) 1.10

Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J Clin Oncol (2003) 1.08

Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc Natl Acad Sci U S A (2005) 1.06

Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation. J Biol Chem (2002) 1.06

PPARalpha in the pathogenesis of fatty liver disease. Hepatology (2004) 1.05

Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer (2009) 1.04

Identification of Smyd4 as a potential tumor suppressor gene involved in breast cancer development. Cancer Res (2009) 1.04

Colorectal cancer screening. J Natl Compr Canc Netw (2013) 1.02

Desmoid tumor of the chest wall with pleural involvement. Ann Thorac Surg (2003) 1.02

Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development. J Biol Chem (2007) 1.02

Multifocal presentation of gangliocytic paraganglioma in the mediastinum and esophagus. Hum Pathol (2004) 1.02

EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol Ther (2009) 1.00

MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling. Mol Cancer Res (2011) 1.00

Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society. Arch Pathol Lab Med (2014) 1.00

FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia. BMC Cancer (2010) 0.99

Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse. Hepatology (2011) 0.97

Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol (2011) 0.95

Solitary fibrous tumor of the pancreas: case report with cytologic and surgical pathology correlation and review of the literature. JOP (2008) 0.94

Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Hum Pathol (2002) 0.93

Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis. Hepatol Res (2004) 0.92

Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer (2010) 0.92

Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Expr (2009) 0.91

Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis. J Biol Chem (2004) 0.90

Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse. Carcinogenesis (2009) 0.89

PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex. Biochem Biophys Res Commun (2006) 0.89

Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis (2003) 0.89

Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood) (2004) 0.89

Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Lab Invest (2010) 0.88

Immunohistochemical detection of the beta4 integrin subunit in pancreatic adenocarcinoma. J Histochem Cytochem (2005) 0.88

Infection and pediatric acute lymphoblastic leukemia. Blood Cells Mol Dis (2008) 0.88

Cyclin D1 expression in melanocytic lesions of the skin. Ann Diagn Pathol (2005) 0.87

PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic. J Pharmacol Exp Ther (2003) 0.87

Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver. J Biol Chem (2007) 0.87

Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system. J Biol Chem (2003) 0.86

Effects of body temperature on ventilator-induced lung injury. J Crit Care (2005) 0.86

Colorectal Cancer Screening Clinical Practice Guidelines. J Natl Compr Canc Netw (2006) 0.86

Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene. Mech Dev (2012) 0.85

Peroxisome proliferator-activated receptor-binding protein null mutation results in defective mammary gland development. J Biol Chem (2005) 0.85

Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.84

Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression. Biochem J (2009) 0.84

Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites. Clin Nucl Med (2005) 0.84

Extensive myxoid change in well-differentiated papillary mesothelioma of the pelvic peritoneum. Ann Diagn Pathol (2002) 0.83

GAS6 is an estrogen-inducible gene in mammary epithelial cells. Biochem Biophys Res Commun (2006) 0.83

Effect of CT image compression on computer-assisted lung nodule volume measurement. Radiology (2005) 0.82

The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase. J Biol Chem (2013) 0.81

Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis. Arthritis Rheum (2013) 0.80

Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver. Gene Expr (2007) 0.80

ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptor. Biochem Biophys Res Commun (2004) 0.79

A 48-year-old woman with skin lesions, renal masses, and spontaneous pneumothorax. Chest (2007) 0.79

Efficient generation of random chromosome deletions. Biotechniques (2007) 0.79

PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression. J Biol Chem (2009) 0.79

Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy. Nat Rev Urol (2010) 0.79

Localized amyloidosis of the nasal and paranasal mucosa: a rare pathology. Am J Otolaryngol (2009) 0.78

PRIC295, a Nuclear Receptor Coactivator, Identified from PPARα-Interacting Cofactor Complex. PPAR Res (2010) 0.78

Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung. Virchows Arch (2011) 0.78

Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis. BMC Gastroenterol (2010) 0.77

Profiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip Biology System. Gene Expr (2002) 0.77

Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice. Int J Oncol (2002) 0.77

Fatal adenovirus pneumonia in a person with AIDS and Burkitt lymphoma: a case report and review of the literature. AIDS Read (2008) 0.76

Loss of BRCA1 expression in sporadic male breast carcinoma. Breast Cancer Res Treat (2002) 0.76